We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$1.79B
(+14%)
Cap. Flow
+$849M
Cap. Flow
% of AUM
5.76%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
1,178
New
178
Increased
473
Reduced
324
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$128M |
| 2 |
Intel
INTC
|
+$88.4M |
| 3 |
Prudential Financial
PRU
|
+$72.7M |
| 4 |
Lam Research
LRCX
|
+$62.6M |
| 5 |
SBA Communications
SBAC
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$98.3M |
| 2 |
Target
TGT
|
+$86.8M |
| 3 |
Occidental Petroleum
OXY
|
+$74.7M |
| 4 |
Synchrony
SYF
|
+$61.6M |
| 5 |
Intercontinental Exchange
ICE
|
+$57.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 13.08% |
| 4 | Consumer Discretionary | 12.97% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Expedia Group
EXPE
$33.3B
| $2.19M | 0.01% |
+13,390
| New | +$2.3M |
|
577
Ezcorp Inc
EZPW
$1.87B
| $2.19M | 0.01% |
362,426
-25,491
| -7% | -$161K |
|
578
Texas Capital Bancshares
TCBI
$4.28B
| $2.18M | 0.01% |
34,296
+8,333
| +32% | +$562K |
|
|
UMPQ
579
DELISTED
Umpqua Holdings Corp
UMPQ
| $2.18M | 0.01% |
+117,992
| New | +$2.2M |
|
|
STEL
580
DELISTED
Stellar Bancorp
STEL
| $2.16M | 0.01% |
79,029
+254
| +0.3% | +$7.65K |
|
581
FB Financial Corp
FBK
$2.94B
| $2.15M | 0.01% |
57,751
+6,963
| +14% | +$289K |
|
582
Generac Holdings
GNRC
$11.6B
| $2.13M | 0.01% |
5,132
-25,256
| -83% | -$8.47M |
|
583
Encore Capital Group
ECPG
$1.99B
| $2.13M | 0.01% |
44,921
-88,273
| -66% | -$3.84M |
|
|
UNVR
584
DELISTED
Univar Solutions Inc.
UNVR
| $2.12M | 0.01% |
86,992
-47,915
| -36% | -$1.2M |
|
585
Avis
CAR
$5.73B
| $2.08M | 0.01% |
26,683
-197
| -0.7% | -$16.3K |
|
|
NVRO
586
DELISTED
NEVRO CORP.
NVRO
| $2.07M | 0.01% |
12,460
| – | – |
|
587
Daktronics
DAKT
$956M
| $2.06M | 0.01% |
312,641
+10,347
| +3% | +$67.6K |
|
588
First Financial Corp
THFF
$924M
| $2.06M | 0.01% |
50,354
+13,043
| +35% | +$579K |
|
|
STMP
589
DELISTED
Stamps.com, Inc.
STMP
| $2.05M | 0.01% |
10,218
-1,402
| -12% | -$275K |
|
|
KE
590
Kimball Electronics
KE
$594M
| $2.04M | 0.01% |
93,965
+58,730
| +167% | +$1.32M |
|
591
Bristow Group
VTOL
$1.37B
| $2.03M | 0.01% |
79,381
+5,617
| +8% | +$152K |
|
|
ELVT
592
DELISTED
Elevate Credit, Inc.
ELVT
| $2.01M | 0.01% |
564,043
+11,863
| +2% | +$41.1K |
|
593
Hilton Worldwide
HLT
$75B
| $2.01M | 0.01% |
16,676
+13,405
| +410% | +$1.67M |
|
|
WSR
594
DELISTED
Whitestone REIT
WSR
| $1.99M | 0.01% |
241,596
+215,393
| +822% | +$1.94M |
|
595
Banner Corp
BANR
$2.38B
| $1.99M | 0.01% |
36,721
+11,886
| +48% | +$673K |
|
596
Invesco
IVZ
$13.4B
| $1.99M | 0.01% |
+74,465
| New | +$2.03M |
|
597
Exelixis
EXEL
$14.1B
| $1.99M | 0.01% |
+109,045
| New | +$2.54M |
|
598
Macy's
M
$6.56B
| $1.98M | 0.01% |
+104,503
| New | +$1.86M |
|
599
Lifecore Biomedical
LFCR
$162M
| $1.96M | 0.01% |
174,461
+8,052
| +5% | +$92.8K |
|
600
STRATTEC Security
STRT
$362M
| $1.95M | 0.01% |
43,869
+14,284
| +48% | +$683K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2021 Portfolio in Review
As of Q2 2021, Jacobs Levy Equity Management held 1,178 positions worth $14.8B, up 14% from $13B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $849M of net new capital in Q2 2021, opening 178 new positions and adding to 473 existing holdings. Its largest new stake was Lam Research: 991,120 shares worth $64.5M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $98.3M trimmed.
- Jacobs Levy Equity Management's largest Q2 2021 buy was Lam Research: 991,120 shares worth $64.5M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q2 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q2 2021 reduction was Qualcomm, cutting an estimated $98.3M.
- Jacobs Levy Equity Management fully exited Occidental Petroleum in Q2 2021, selling an estimated $74.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q2 2021.
- Jacobs Levy Equity Management opened 178 new positions and closed 161 in Q2 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.